BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17891620)

  • 1. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
    Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study.
    Bondarenko O; Beek AM; Twisk JW; Visser CA; van Rossum AC
    Eur Heart J; 2008 Aug; 29(16):2000-5. PubMed ID: 18556713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.
    Selvanayagam JB; Kardos A; Francis JM; Wiesmann F; Petersen SE; Taggart DP; Neubauer S
    Circulation; 2004 Sep; 110(12):1535-41. PubMed ID: 15353496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
    Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
    J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ; Wu E; Rafael A; Chen EL; Parker MA; Simonetti O; Klocke FJ; Bonow RO; Judd RM
    N Engl J Med; 2000 Nov; 343(20):1445-53. PubMed ID: 11078769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction.
    Park S; Choi BW; Rim SJ; Shim CY; Ko YG; Kang SM; Ha JW; Jang Y; Chung N; Choe KO; Cho SY
    J Card Fail; 2006 Mar; 12(2):93-9. PubMed ID: 16520255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
    Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM
    Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions.
    Baks T; van Geuns RJ; Duncker DJ; Cademartiri F; Mollet NR; Krestin GP; Serruys PW; de Feyter PJ
    J Am Coll Cardiol; 2006 Feb; 47(4):721-5. PubMed ID: 16487835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.
    Kwong RY; Chan AK; Brown KA; Chan CW; Reynolds HG; Tsang S; Davis RB
    Circulation; 2006 Jun; 113(23):2733-43. PubMed ID: 16754804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
    Kwong RY; Korlakunta H
    Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
    Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
    Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved wall motion of late gadolinium-enhanced myocardium after complete surgical revascularization.
    Oh SJ; Park EA; Lee W; Hwang HY; Kim KB
    Ann Thorac Surg; 2015 May; 99(5):1554-60. PubMed ID: 25757761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement.
    Casolo G; Minneci S; Manta R; Sulla A; Del Meglio J; Rega L; Gensini G
    Am Heart J; 2006 Jan; 151(1):101-8. PubMed ID: 16368300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging.
    Roes SD; Mollema SA; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
    Am J Cardiol; 2009 Aug; 104(3):312-7. PubMed ID: 19616660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics.
    Baks T; van Geuns RJ; Biagini E; Wielopolski P; Mollet NR; Cademartiri F; van der Giessen WJ; Krestin GP; Serruys PW; Duncker DJ; de Feyter PJ
    J Am Coll Cardiol; 2006 Jan; 47(1):40-4. PubMed ID: 16386662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of coronary artery collaterals on infarct size assessed by serial cardiac magnetic resonance imaging after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Yoon SJ; Ko YG; Kim JS; Moon JY; Kim YJ; Park S; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Coron Artery Dis; 2009 Nov; 20(7):440-5. PubMed ID: 19730371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.